Cite

HARVARD Citation

    Fitzgerald, D. et al. (2018). Changing respiratory expectations with the new disease trajectory of nusinersen treated spinal muscular atrophy [SMA] type 1. Paediatric respiratory reviews. pp. 11-17. [Online]. 
  
Back to record